TC BioPharm shares are trading lower after the company announced the pricing of a 2 million unit offering at $1 per unit.
Portfolio Pulse from Benzinga Newsdesk
TC BioPharm shares are trading lower after the company announced the pricing of a 2 million unit offering at $1 per unit.
August 13, 2024 | 8:57 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TC BioPharm shares are trading lower following the announcement of a 2 million unit offering priced at $1 per unit.
The announcement of a unit offering typically dilutes existing shares, leading to a decrease in share price. The market's immediate reaction to the news has been negative, causing the stock to trade lower.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100